This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Latanoprost

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • latanoprost is structurally related to prostaglandin F2alpha
  • probably works via mainly increasing uveoscleral drainage
  • administered as one drop daily in the evening
  • possible side effects include:
    • minor redness and irritation in the eyes
    • thickening, darkening and lengthening of eyelashes
    • irreversible darkening of the iris (in 30% of patients) - most often in those with mixed-clour irides - this effect is more likely when the drug has been used for over 6 months
  • contraindications include:
    • pregnancy and breast feeding
    • patienst with risk factors for cystoid macular oedema - although it has not been proven to cause this condition
  • an alternative first-line therapy to timolol (1) because more effective at reducing intraocular pressure, causes fewer systemic unwanted effects, has fewer contraindications and needs to be used only once daily

The summary of product characteristics must be consulted before prescribing this drug

Reference:

  1. Drug and Therapeutics Bulletin (2003), 41 (2), 12-14.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.